HomeAI · summaries
Storia in 2 fonti
ARPA-H launches $63M effort to build FDA-authorized AI agents for heart failure care
The Advanced Research Projects Agency for Health (ARPA-H) launched a $62.7 million effort to develop a patient-facing agentic clinical AI system for cardiovascular care, specifically to treat heart | A key aspect of the initiative is close collaboration with the FDA to establish a regulatory framework for a new class of autonomous clinical AI.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
endpoints.news
ARPA-H selects companies to build AI tools for heart disease
ARPA-H invests $62.7M in ADVOCATE program; UpDoc, Tempus AI & Atman Health to build FDA-authorized AI tools for heart disease care over 4 years.
- ·
The blueprint for clinical AI
ARPA-H launched ADVOCATE, funding UpDoc, Tempus AI & Atman Health to build FDA-authorized AI agents for heart failure treatment within 24 months.
